Brought to you by 
Lifecore Biomedical taken private through purchase by Warburg
22 Jan 2008
Executive Summary
Biomaterials developer Lifecore Biomedical has agreed to be acquired by private equity firm Warburg Pincus in a $230mm deal ($17 per share for each of Lifecore's 13.5mm outstanding shares; a 26% premium).
Deal Industry
- Biotechnology
- Medical Devices
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Biomaterials
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lifecore Biomedical taken private through purchase by Warburg
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice